Zinzino Reports Strong Year-End Growth, Proposes 50% Dividend Increase

Zinzino AB, based in Gothenburg, Sweden, announced significant financial growth in its year-end report for 2025, highlighting a remarkable 45% increase in fourth-quarter revenue. The company’s revenue for the quarter reached SEK 1,035.3 million, up from SEK 713.5 million during the same period last year. This growth reflects a 52% increase in local currencies, bolstered by enhanced profitability across its operations.

The company reported an impressive rise in EBITDA, which climbed to SEK 175.2 million, compared to SEK 72.9 million in the previous year. This resulted in an EBITDA margin of 16.9%, a marked improvement from 10.2% in the same quarter of 2024. The increase in profitability was primarily attributed to a stronger gross profit and synergies gained from the acquisition of Zurvita, a move that has strategically positioned Zinzino for sustainable growth.

Strategic Acquisitions and New Products

During the fourth quarter, Zinzino also acquired a 35% stake in Xion International Group, focusing on the production of algae through bioreactors. This initiative aims to secure a sustainable supply of omega-3 for the company’s flagship product, BalanceOil. Additionally, the acquisition of Sanki’s assets is expected to enhance distribution capabilities across North and South America. The company also launched the Gut Health Test, further expanding its product offerings.

For the full year, Zinzino reported total revenue of SEK 3,337.5 million, representing a 51% increase compared to SEK 2,207.8 million in 2024. The EBITDA for the year amounted to SEK 443.4 million, with an EBITDA margin of 13.3%, up from 11.4% the previous year. Zinzino’s net profit reached SEK 324.5 million, translating to a net profit per share of SEK 9.09 before dilution.

Dividend Proposal and Future Outlook

In light of these robust results, the Board of Directors plans to propose a dividend of SEK 6.00 per share at the Annual General Meeting scheduled for June 2, 2026. This marks a substantial increase from the SEK 4.00 per share distributed in the previous year, reflecting a total payout of SEK 217.9 million before dilution.

Following the close of the reporting period, Zinzino made headlines with the acquisition of It Works!, aimed at enhancing its distribution power in North America and Europe. This strategic move is expected to further strengthen Zinzino’s market presence and operational capabilities.

As Zinzino continues to expand its portfolio and improve its profitability, stakeholders will be closely watching how these initiatives translate into future growth and shareholder value. The company’s proactive approach to acquisitions and product development underscores its commitment to maintaining a competitive edge in the health and wellness sector.